The Senate last night voted 98-2 to approve the Patient Right to Know Drug Prices Act (S. 2554), a bill that would prohibit private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance. Some health insurance contracts prevent pharmacists from informing patients when the cash price for their prescription costs less than their insurance cost-sharing arrangement unless the individual asks. The Senate earlier this month passed a similar bill that applies to patients in Medicare Advantage and Medicare Part D plans. The House Energy and Commerce Committee last week approved similar legislation for Medicare and private health plans.

Related News Articles

Headline
The AHA today voiced support for the Recovering Excessive Funds for Unused and Needless Drugs Act (S. 551), legislation that would incentivize manufacturers to…
Headline
The House Ways and Means Committee today approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported…
Headline
Idaho Gov. Brad Little this week signed legislation adding work requirements to the state’s plan to expand Medicaid coverage to low-income adults.
Headline
Sen. Bernie Sanders, I-Vt., and 14 of his Democratic colleagues today introduced the Medicare for All Act of 2019, legislation that would create a national…
Headline
Reps. Earl Blumenauer, D-Ore., and Markwayne Mullin, R-Okla., yesterday reintroduced  the Overdose Prevention and Patient Safety Act (H.R. 2062), AHA-supported…
Headline
The House Committee on Energy and Commerce yesterday passed a number of AHA-supported bills that would lower prescription drug costs and strengthen the…